NO20003962L - Farmasøytiske preparater - Google Patents

Farmasøytiske preparater

Info

Publication number
NO20003962L
NO20003962L NO20003962A NO20003962A NO20003962L NO 20003962 L NO20003962 L NO 20003962L NO 20003962 A NO20003962 A NO 20003962A NO 20003962 A NO20003962 A NO 20003962A NO 20003962 L NO20003962 L NO 20003962L
Authority
NO
Norway
Prior art keywords
pharmaceuticals
Prior art date
Application number
NO20003962A
Other languages
English (en)
Other versions
NO20003962D0 (no
NO329041B1 (no
Inventor
Nikki Thoennes Brooks
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20003962D0 publication Critical patent/NO20003962D0/no
Publication of NO20003962L publication Critical patent/NO20003962L/no
Publication of NO329041B1 publication Critical patent/NO329041B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20003962A 1998-02-06 2000-08-04 Farmasoytisk sammensetning NO329041B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802472.2A GB9802472D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en) 1998-02-06 1999-02-04 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO20003962D0 NO20003962D0 (no) 2000-08-04
NO20003962L true NO20003962L (no) 2000-09-27
NO329041B1 NO329041B1 (no) 2010-08-02

Family

ID=10826520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003962A NO329041B1 (no) 1998-02-06 2000-08-04 Farmasoytisk sammensetning

Country Status (39)

Country Link
US (1) US6641843B1 (no)
EP (1) EP1051156B1 (no)
JP (1) JP3560550B2 (no)
KR (1) KR100564854B1 (no)
CN (2) CN101239063A (no)
AP (1) AP1212A (no)
AR (1) AR017455A1 (no)
AT (1) ATE237309T1 (no)
AU (1) AU754255B2 (no)
BR (1) BR9907649A (no)
CA (1) CA2319010C (no)
CO (1) CO5070673A1 (no)
CZ (1) CZ299608B6 (no)
DE (1) DE69906934T2 (no)
DK (1) DK1051156T3 (no)
EA (1) EA002916B1 (no)
EE (1) EE04217B1 (no)
ES (1) ES2196779T3 (no)
GB (1) GB9802472D0 (no)
HK (1) HK1030552A1 (no)
HR (1) HRP20000530B1 (no)
HU (1) HU228315B1 (no)
ID (1) ID26215A (no)
IL (2) IL137403A0 (no)
IS (1) IS2200B (no)
MA (1) MA26604A1 (no)
MY (1) MY121043A (no)
NO (1) NO329041B1 (no)
NZ (1) NZ505811A (no)
PE (1) PE20000271A1 (no)
PL (1) PL194558B1 (no)
PT (1) PT1051156E (no)
RS (1) RS49953B (no)
SI (1) SI1051156T1 (no)
SK (1) SK284397B6 (no)
TR (1) TR200002293T2 (no)
TW (1) TWI222878B (no)
WO (1) WO1999039691A2 (no)
ZA (1) ZA99890B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2305680A3 (en) * 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567703A (en) 1988-01-20 1996-10-22 Regents Of The University Of Minnesota Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
WO1997049410A1 (en) * 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
US6124319A (en) * 1997-01-21 2000-09-26 Merck & Co., Inc. 3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6177464B1 (en) * 1997-03-14 2001-01-23 Sepracor, Inc. Ring opening metathesis of alkenes
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt

Also Published As

Publication number Publication date
HUP0100802A2 (hu) 2001-08-28
HRP20000530A2 (en) 2001-02-28
AR017455A1 (es) 2001-09-05
EE04217B1 (et) 2004-02-16
CN1296406A (zh) 2001-05-23
EA002916B1 (ru) 2002-10-31
HUP0100802A3 (en) 2001-12-28
ID26215A (id) 2000-12-07
HU228315B1 (en) 2013-03-28
MA26604A1 (fr) 2004-12-20
DE69906934D1 (de) 2003-05-22
EE200000459A (et) 2002-02-15
MY121043A (en) 2005-12-30
KR20010040714A (ko) 2001-05-15
IL137403A (en) 2007-07-24
PT1051156E (pt) 2003-09-30
TR200002293T2 (tr) 2000-11-21
BR9907649A (pt) 2000-10-31
KR100564854B1 (ko) 2006-03-30
ES2196779T3 (es) 2003-12-16
GB9802472D0 (en) 1998-04-01
US6641843B1 (en) 2003-11-04
NZ505811A (en) 2002-09-27
DK1051156T3 (da) 2003-06-23
IS5569A (is) 2000-07-20
AU754255B2 (en) 2002-11-07
IS2200B (is) 2007-02-15
HK1030552A1 (en) 2001-05-11
DE69906934T2 (de) 2004-02-12
EP1051156B1 (en) 2003-04-16
PL194558B1 (pl) 2007-06-29
YU48200A (sh) 2003-02-28
CA2319010A1 (en) 1999-08-12
CA2319010C (en) 2008-06-10
EP1051156A2 (en) 2000-11-15
CN101239063A (zh) 2008-08-13
SI1051156T1 (en) 2003-08-31
TWI222878B (en) 2004-11-01
CZ299608B6 (cs) 2008-09-17
PE20000271A1 (es) 2000-04-17
JP3560550B2 (ja) 2004-09-02
CO5070673A1 (es) 2001-08-28
SK284397B6 (sk) 2005-03-04
WO1999039691A2 (en) 1999-08-12
AU2722199A (en) 1999-08-23
SK11682000A3 (sk) 2001-04-09
NO20003962D0 (no) 2000-08-04
RS49953B (sr) 2008-09-29
PL342628A1 (en) 2001-06-18
JP2002502808A (ja) 2002-01-29
AP1212A (en) 2003-11-12
ATE237309T1 (de) 2003-05-15
HRP20000530B1 (en) 2003-10-31
IL137403A0 (en) 2001-07-24
NO329041B1 (no) 2010-08-02
ZA99890B (en) 2000-08-04
EA200000736A1 (ru) 2001-04-23
WO1999039691A3 (en) 1999-10-28
AP2000001878A0 (en) 2000-09-30
CZ20002867A3 (cs) 2001-02-14

Similar Documents

Publication Publication Date Title
DE69940487D1 (de) Fluidumverdichter
DE69935706D1 (de) Funkkommunnikationssystem
NO20010382D0 (no) Agglutineringsundersökelse
FI980221A0 (fi) Refraktometer
ID23735A (id) Tablet trovafloksasin mesilat
DE69939653D1 (de) Erkstoff
FI980329A0 (fi) Optiskt telekommunikationsnaet
FI980739A0 (fi) Timmerknut
DE59807217D1 (de) Nadellager
DK1051156T3 (da) Farmaceutiske præparater
DE69942000D1 (de) Sicherheitstontaube
DE69917702D1 (de) Filamentgarnaufwickelmaschine
FI980281A0 (fi) Styrkoppling foer en grupphanteringsanordning
SE9801216D0 (sv) Pharmaceuticals
FI980030A0 (fi) Avfyringsmekanism foer skjutvapen
ATA126298A (de) Verpuffungsklappe
SE9901098D0 (sv) Verteilerkasten
SE9800469D0 (sv) Pharmaceuticals
DK0969815T3 (da) Farmaceutiske præparater
SE9702958D0 (sv) Pharmaceuticals
SE9902941D0 (sv) Pharmaceuticals
SE9902940D0 (sv) Pharmaceuticals
SE9902939D0 (sv) Pharmaceuticals
SE9902945D0 (sv) Pharmaceuticals
UA2845S (uk) Таблетка

Legal Events

Date Code Title Description
MK1K Patent expired